|
CUL4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.914100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.655300E-03 |
| Normal-vs-Stage2 |
4.021600E-01 |
| Normal-vs-Stage3 |
6.440200E-01 |
| Normal-vs-Stage4 |
5.764200E-01 |
| Stage1-vs-Stage2 |
6.629800E-01 |
| Stage1-vs-Stage3 |
5.141600E-01 |
| Stage1-vs-Stage4 |
6.033800E-01 |
| Stage2-vs-Stage3 |
8.295200E-01 |
| Stage2-vs-Stage4 |
8.754600E-01 |
| Stage3-vs-Stage4 |
9.629400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.239910E-02 |
| Normal-vs-AfricanAmerican |
2.125800E-01 |
| Normal-vs-Asian |
4.257000E-01 |
| Caucasian-vs-AfricanAmerican |
6.561400E-01 |
| Caucasian-vs-Asian |
7.491600E-01 |
| AfricanAmerican-vs-Asian |
6.540800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.317920E-02 |
| Normal-vs-Female |
5.360000E-01 |
| Male-vs-Female |
2.719600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.362010E-01 |
| Normal-vs-Extreme_Weight |
8.593800E-04 |
| Normal-vs-Obese |
7.076800E-01 |
| Normal-vs-Extreme_Obese |
3.036600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.921000E-01 |
| Normal_Weight-vs-Obese |
4.076600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.623800E-01 |
| Extreme_Weight-vs-Obese |
4.744300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.831200E-01 |
| Obese-vs-Extreme_Obese |
4.728600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.072200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.836600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.322900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.115800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.026200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.259600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.800800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.526000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.293600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.526800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.426300E-02 |
| Normal-VS-Type2 PRCC |
1.511610E-01 |
| Normal-VS-KIRP CIMP |
9.406100E-02 |
| Normal-VS-Unclassified PRCC |
5.374400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.831200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.672800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.129800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.537600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.484400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.449000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.433500E-02 |
| Normal-vs-N1 |
8.784400E-01 |
| Normal-vs-N2 |
5.78199999999862E-05 |
| N0-vs-N1 |
2.986800E-01 |
| N0-vs-N2 |
1.796830E-01 |
| N1-vs-N2 |
8.093700E-02 |
|
|
